LAS VEGAS, March 27 /CNW/ -- Skinvisible, Inc. (OTC Bulletin Board: SKVI)
(Website: www.skinvisible.com) announced today that its licensee Cross Global
Inc. ("CGI"), dba as Sunless Beauty (www.sunlessbeauty.com) will debut this
week on QVC, America's premier television shopping channel, reaching more than
90 million homes across the United States.
Initially Solerra will launch its highly successful UV free sunless
tanning mitt for face and body. Other Solerra suncare products will follow
including a sunless tanning lotion, moisturizing cream and a sunscreen product
with SPF 30. Solerra's product line is formulated with Skinvisible's patented
delivery system; Invisicare(R). Invisicare enhances the sunless tanning
product by minimizing streaking upon application and providing a tan that
resists fading. Additionally, Invisicare intensifies the moisturizing effect,
leaving the skin softer and smoother.
"This is a significant marketing achievement on the part of Sunless
Beauty," said Terry Howlett, President of Skinvisible, Inc. "The broad
audience exposure provided by this at home shopping network is invaluable.
Revenue for Skinvisible is received from both the Invisicare sales and
The launch follows Solerra's product debut at the Academy Awards last
month. Company executives had the opportunity to distribute the Solerra
product line to actors and actresses present at the Awards at a post Oscar
party. There was a high level of interest generated from the Hollywood
community at this event according to Company President Angie Trelstad.
Sunless Beauty's plan is to also sell the Solerra products nationally
through high end retail beauty stores in the US and Canada in 2007 and is
seeking distributors for Europe and Australia.
Skinvisible has patented its technology and trademarked its polymer
delivery system Invisicare(R). Invisicare is a combination of hydrophilic and
hydrophobic polymers that hold active ingredients on the skin for extended
periods of time. They are non-occlusive and allow normal skin respiration and
perspiration while moisturizing and protecting against exposure from a wide
variety of environmental irritants. See: www.invisicare.com.
About Skinvisible Pharmaceuticals, Inc.
Headquartered in Las Vegas, Nevada, Skinvisible Pharmaceuticals is a
research-and-development company who's primary business objective is to
license its technology and formulated products to manufacturers of Rx and OTC
skincare products. See www.skinvisible.com.
This press release contains 'forward looking' statements within the
meaning of Section 21A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, and are subject to the
safe harbors created thereby. Such statements involve certain risks and
uncertainties associated with an emerging company. Actual results could differ
materially from those projected in the forward looking statements as a result
of risk factors discussed in Skinvisible, Inc. reports on file with the U.S.
Securities and Exchange Commission (including, but not limited to, a report on
Form 10-QSB for the quarter ending September 30, 2006.
Terry Howlett, President/CEO
Skinvisible Pharmaceuticals, Inc
For further information:
For further information: Terry Howlett, President/CEO of Skinvisible
Pharmaceuticals, Inc., +1-702-433-7154, email@example.com Web Site: